C100 AB (publ) (XSAT:C100)
Sweden · Delayed Price · Currency is SEK 4.140
0.00 (0.00%)
At close: Aug 6, 2026
C100 AB Revenue
C100 AB had revenue of -900.00K SEK in the twelve months ending March 31, 2026. In the year 2025, C100 AB had annual revenue of 3.30M, down -1.20%.
Revenue (ttm)
-900.00K
Revenue Growth
-1.20%
P/S Ratio
-172,286.63
Revenue / Employee
-15.60
Employees
1
Market Cap
13.44M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.30M | -40.12K | -1.20% |
| Dec 31, 2024 | 3.34M | 2.20M | 193.09% |
| Dec 31, 2023 | 1.14M | -2.19M | -65.79% |
| Dec 31, 2022 | 3.33M | -2.24M | -40.17% |
| Dec 31, 2021 | 5.57M | -974.24K | -14.89% |
| Dec 31, 2020 | 6.54M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Nilsson Special Vehicles AB | 156.20M |
| Exalt AB | 45.66M |
| Risk Intelligence | 39.62M |
| Tessin Nordic Holding AB | 11.59M |
| Inhalation Sciences Sweden AB | 6.38M |
| Monivent AB | 4.77M |
| Biofrigas Sweden AB | 469.78K |
| Respiratorius AB | 30.07K |
C100 AB News
- 2 months ago - C100 AB Quarterly report: Q1 2026 - Filings
- 6 months ago - C100 AB Quarterly report: Q4 2025 - Filings
- 6 months ago - C100 AB Annual report: Q4 2025 - Filings
- 10 months ago - C100 AB Quarterly report: Q3 2025 - Filings
- 1 year ago - C100 AB Quarterly report: Q2 2025 - Filings